An open‐label study to evaluate the long‐term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension

Overview of attention for article published in Clinical and Translational Allergy, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#36 of 767)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 27 X users
patent: 7 patents

facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Methods of detecting plasma kallikrein

Grant US-11505620-B2

United States of America

Nucleic acids encoding plasma kallikrein binding proteins

Grant US-11401346-B2

United States of America

Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Grant US-11286307-B2

United States of America

Compositions and methods for treatment of diabetic macular edema

Grant US-11046785-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.